newsfilter
← Latest News
ACCESS Newswire·

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

TORONTO, ON / ACCESSWIRE / June 27, 2024 / FSD Pharma Inc. , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech